Novel SDHD germ-line mutations in pheochromocytoma patients

European Journal of Clinical Investigation

Volumn 37, Issue 7, 2007, Pages 544-551

  Neumayer, C ^a   Moritz, A ^b   Asari, R ^a   Weinhausel A ^c   Holzenbein T ^a   Kretschmer, G ^a   Niederle, B ^a   Haas, O A ^b,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c ARC SEIBERSDORF RESEARCH GMBH   (Austria)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Germ line mutations; Pheochromocytoma; SDHD

Indexed keywords

ABDOMINAL TUMOR; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CAROTID BODY TUMOR; CHEMODECTOMA; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GERM LINE; HETEROZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOP CODON; THORAX TUMOR;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 34250373771     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01822.x     Document Type: Article

References (49)

1. Dahia PL. Evolving concepts in pheochromocytoma and paraganglioma. Curr Opin Oncol 2006 18 : 1 8.
2. Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 2005 89 : 193 201.
3. Young WF Jr., Abboud AL. Editorial: paraganglioma - all in the family. J Clin Endocrinol Metab 2006 91 : 790 2.
4. Pheochromocytoma. First International Symposium on Pheochromocytoma (ISP2005): 2005. Bethesda, MA: National Institutes of Health. Ann N Y Acad Sci 2006 1073 : 1 588.
5. Bornstein SR, Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Ann N Y Acad Sci 2006 1073 : 94 103.
6. De Lellis RA, Lloyd RV, Heitz PU, Eng C. WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France. IARC Press 2004.
7. Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP. The genetic basis of pheochromocytoma. Front Horm Res 2004 31 : 45 60.
8. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002 346 : 1459 66.
9. Neumann HP, Cybulla M, Shibata H, Oya M, Naruse M, Higashihara E et al. New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med 2005 54 : 15 21.
10. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N et al. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J Med Genet 2003 40 : e75.
11. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005 23 : 8812 8.
12. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006 91 : 827 36.
13. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000 287 : 848 51.
14. Gimm O, Armanios M, Dziema H, Neumann HP, Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 2000 60 : 6822 5.
15. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000 26 : 268 70.
16. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001 69 : 49 54.
17. Dannenberg H, van Nederveen FH, Abbou M, Verhofstad AA, Komminoth P, de Krijger RR et al. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD. J Clin Oncol 2005 23 : 1894 901.
18. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004 292 : 943 51.
19. Aguiar RC, Cox G, Pomeroy SL, Dahia PL. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. J Clin Endocrinol Metab 2001 86 : 2890 4.
20. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001 357 : 1181 2.
21. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002 39 : 617 22.
22. Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero JC, Diez JJ et al. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur J Hum Genet 2002 10 : 457 61.
23. Dannenberg H, Dinjens WN, Abbou M, Van Urk H, Pauw BK, Mouwen D et al. Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma. Clin Cancer Res 2002 8 : 2061 6.
24. Kytölä S, Nord B, Elder EE, Carling T, Kjellman M, Cedermark B et al. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Genes Chromosomes Cancer 2002 34 : 325 32.
25. Perren A, Barghorn A, Schmid S, Saremaslani P, Roth J, Heitz PU et al. Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients. Oncogene 2002 21 : 7605 8.
26. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP et al. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 2004 89 : 5694 9.
27. Cascon A, Ruiz-Llorente S, Cebrian A, Leton R, Telleria D, Benitez J et al. G12S and H50R variations are polymorphisms in the SDHD gene. Genes Chromosomes Cancer 2003 37 : 220 1.
28. Montani M, Schmitt AM, Schmid S, Locher T, Saremaslani P, Heitz PU et al. No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma. Endocr Relat Cancer 2005 12 : 1011 6.
29. Riemann K, Sotlar K, Kupka S, Braun S, Zenner HP, Preyer S et al. Chromosome 11 monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases. Cancer Genet Cytogenet 2004 150 : 128 35.
30. Baysal BE. Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet 2004 129 : 85 90.
31. Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004 41 : 703 9.
32. Cascon A, Montero-Conde C, Ruiz-Llorente S, Mercadillo F, Leton R, Rodriguez-Antona C et al. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? Genes Chromosomes Cancer 2006 45 : 213 9.
33. Jimenez C, Cote G, Arnold A, Gagel RF. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 2006 91 : 2851 8.
34. Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 2006 1073 : 1 20.
35. Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 2005 6 : 39.
36. Fokkema IF, den Dunnen JT, Taschner PE. LOVD: Easy creation of a locus-specific sequence variation database using an 'LSDB-in-a-Box' approach. Hum Mutat 2005 26 : 63 8.
37. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003 3 : 193 202.
38. Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer 2001 31 : 255 63.
39. Lee SC, Chionh SB, Chong SM, Taschner PE. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect? Laryngoscope 2003 113 : 1055 8.
40. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 2001 31 : 274 81.
41. Simi L, Sestini R, Ferruzzi P, Gagliano MS, Gensini F, Mascalchi M et al. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. J Med Genet 2005 42 : e52.
42. Cascon A, Ruiz-Llorente S, Fraga MF, Leton R, Telleria D, Sastre J et al. Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 2004 41 : e30.
43. De Preter K, Vandesompele J, Hoebeeck J, Vandenbroecke C, Smet J, Nuyts A et al. No evidence for involvement of SDHD in neuroblastoma pathogenesis. BMC Cancer 2004 4 : 55.
44. Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C et al. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol 2003 59 : 728 33.
45. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003 63 : 5615 21.
46. Hensen EF, Jordanova ES, van Minderhout IJ, Hogendoorn PC, Taschner PE, van der Mey AG et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004 23 : 4076 83.
47. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Human Genet 2003 113 : 228 37.
48. Lam KY, Chan AC, Wong WM, Lam KS. A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese. Eur J Surg Oncol 1993 19 : 421 7.
49. McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 2000 30 : 648 52.